Skip to main content
# Title Department Research Year
91 Carbon Nano-Dots based potentiometric sensor for the assay of the antiviral agent; Valacyclovir: In-Depth DFT Calculations, application to the pharmaceutical formulation and greenness assessment Department of Medicinal Chemistry 2024
92 Spectral, XRD, morphological, DFT, and molecular modeling investigations of newly prepared isatin Schiff base complexes Department of Medicinal Chemistry 2024
93 Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma Department of Medicinal Chemistry 2024
94 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability Department of Clinical Pharmacy 2024
95 New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
96 First electrochemical nanosensor for ultrasensitive quantification of MET inhibitor, capmatinib based on carbon nanofiber networks incorporated with hybrid nanofiller nanogold-loaded porous acetylene black Department of Pharmaceutical Analytical Chemistry 2024
97 Light microscopical and parasitological analyses revealed the beneficial effects of silver nanoparticles and various myrrh extracts against Trichinella spiralis infection in mice Department of Pharmacognosy 2024
98 Cobalt-modulated dual emission carbon dots for ratiometric fluorescent vancomycin detection† Department of Pharmaceutical Analytical Chemistry 2024
99 Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
100 Tetrahydrocarbazoles incorporating 5-arylidene-4-thiazolinones as potential antileukemia and antilymphoma targeting tyrosine kinase and tubulin polymerase enzymes: Design, synthesis, structural, biological and molecular docking studies Department of Pharmaceutical Organic Chemistry 2024